Global Analysis of DNA Methylation Alteration Induced by Jinfukang in Human Lung Cancer Cells

来源 :第四届国际肿瘤表观遗传学大会 | 被引量 : 0次 | 上传用户:qwertys
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Introduction DNA methylation plays a critical role in the development and progression of various cancers.Lung cancer is one of the leading causes of cancer-related deaths and non-small cell lung carcinoma (NSCLC) accounts for approximately 80% of lung cancer diagnoses.
其他文献
Cancer is a highly heterogeneous disease of the dysproliferating cells, suffering from extensive genomic and epigenomic defects.DNA methylation is the best characterized epigenetic mechanism, ensuring
会议
Tumor samples are unavoidably contaminated by coexisting normal cells, but assessment of the cancer cell fraction is important to improve the accuracy of molecular studies.To estimate the cancer cell
会议
RASSF10 was frequently found to be methylated in different cancers.To understand the mechanism of RASSF10 in colorectal carcinogenesis, 8 colorectal cancer cell lines, 89 samples of primary colorectal
会议
BACKGROUND: Increasing evidence indicates that cell fate determination factor DACH1 functions as a tumor suppressor.Specifically, in estrogen receptor positive (luminal), elevated expression of DACH1
会议
Background: DNA methylation patterns are critical for genome stability and gene transcription, and are initiated by de novo methylases DNMT3a/3b adding methyl groups to CG dinucleotides in the hypomet
Unlike genetic aberrations, epigenetic alterations do not modify the DNA coding sequence, and can be reversed pharmacologically.Identifying a particular epigenetic alteration such as abnormal DNA meth
Non-coding RNAs (ncRNAs) have been implicated in diseases and identified to play important roles in various biological processes.NONCODE (http://www.bioinfo.org/noncode/) is an integrated knowledge da
会议
Solid tumor patients when progressed into advanced stages have poor prognosis even treated with intensive salvage regimens and are welcome subjects for clinical trial of new agents.Aberrant DNA methyl
会议
Epigenetic-modulating agents can concurrently target multiple aberrant or compensatory signaling pathways found in cancer cells.However, existing epigenetic-modulating agents in cancer treatment have
会议
The treatment outcome of elderly patients with acute myeloid leukemia(AML) was unsatisfied generally and novel approaches was necessitated.We conducted a prospective singlearm, multicenter, phase-Ⅱ tr